MARKET

JUNS

JUNS

JUPITER NEUROSCIENCES, INC.
NASDAQ
3.001
-0.079
-2.57%
Opening 13:13 09/09 EDT
OPEN
3.060
PREV CLOSE
3.080
HIGH
3.238
LOW
2.940
VOLUME
14.79K
TURNOVER
--
52 WEEK HIGH
137.96
52 WEEK LOW
2.880
MARKET CAP
3.96M
P/E (TTM)
-0.1616
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at JUNS last week (0831-0904)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 08/31 21:06
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 08/31 17:06
Dow Falls Over 300 Points; SAIC Shares Jump After Upbeat Q2 Results
Benzinga · 08/31 14:14
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/31 12:06
Weekly Report: what happened at JUNS last week (0824-0828)?
Weekly Report · 08/31 09:15
Why Webuy Global Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/31 08:53
Jupiter Neurosciences Tumbles on Nasdaq Delisting Notice
Dow Jones · 08/28 22:00
More
About JUNS
Jupiter Neurosciences, Inc. is a clinical-stage biopharmaceutical company advancing a therapeutic pipeline targeting central nervous system disorders and neuroinflammation. The Company's lead program, JOTROL - a proprietary, enhanced-bioavailability resveratrol formulation - is in a Phase IIa clinical trial for Parkinson's disease. The JOTROL delivery platform allows resveratrol to be consumed in an easily consumable, oral softgel in a patented micellar form. Delivered via the JOTROL platform, resveratrol infuses blood plasma and the central nervous system, and crosses the blood brain barrier, unlocking the compound's potential as a therapeutic for neurodegenerative and neurological diseases, without the GI issues. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a softgel capsule. The Company also commercializes Nugevia, a consumer longevity supplement. It also has rights in ALA-002.

Webull offers Jupiter Neurosciences Inc stock information, including NASDAQ: JUNS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JUNS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JUNS stock methods without spending real money on the virtual paper trading platform.